Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease
touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO
Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes.
The expert:
Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.